OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
64 hedge funds and large institutions have $27.5M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+1
Holders Change %
+1.59%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
14
Closed
8
Calls
$327K
Puts
$1.15M
Net Calls
-$826K
Net Calls Change
-$826K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$2.37M |
| 2 |
Millennium Management
New York
|
$1.03M |
| 3 |
Morgan Stanley
New York
|
$743K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$993K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$233K |
